M. Silva

LBA66 Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: Results from the EORTC-ETOP NIVOTHYM phase II trial

N. Girard, R. Stahel, S. Cedrés, 2021, Annals of Oncology.

1361MO 8-month PSA strongly predicts outcomes of men with metastatic castration-sensitive prostate cancer in the PEACE-1 phase III trial

J. McCaffrey, F. Calabrò, A. Thiery-Vuillemin, 2022, Annals of Oncology.